Literature DB >> 35244755

Pancreatic neuroendocrine neoplasms: a 2022 update for radiologists.

Samuel J Galgano1, Ajaykumar C Morani2, Dheeraj R Gopireddy3, Kedar Sharbidre4, David D B Bates5, Ajit H Goenka6, Hina Arif-Tiwari7, Malak Itani8, Amir Iravani8, Sanaz Javadi2, Silvana Faria2, Chandana Lall3, Emily Bergsland9, Sadhna Verma10, Isaac R Francis11, Daniel M Halperin12, Deyali Chatterjee13, Priya Bhosale2, Motoyo Yano14.   

Abstract

Pancreatic neuroendocrine neoplasms (PaNENs) are a unique group of pancreatic neoplasms with a wide range of clinical presentations and behaviors. Given their heterogeneous appearance and increasing detection on cross-sectional imaging, it is essential that radiologists understand the variable presentation and distinctions PaNENs display compared to other pancreatic neoplasms. Additionally, some of these neoplasms may be hormonally functional, and it is imperative that radiologists be aware of the common clinical presentations of hormonally active PaNENs. Knowledge of PaNEN pathology and treatments may influence which imaging modality is optimal for each patient. Each imaging modality used for PaNENs has distinct advantages and disadvantages, particularly in different treatment settings. Thus, the focus of this manuscript is to provide an update for the radiologist on PaNEN pathology, imaging, and treatments.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Neuroendocrine; PaNEN; Pancreas

Year:  2022        PMID: 35244755     DOI: 10.1007/s00261-022-03466-9

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  44 in total

1.  Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms.

Authors:  M Heetfeld; C N Chougnet; I H Olsen; A Rinke; I Borbath; G Crespo; J Barriuso; M Pavel; D O'Toole; T Walter
Journal:  Endocr Relat Cancer       Date:  2015-06-25       Impact factor: 5.678

2.  Epidemiologic trends and prognostic risk factors of patients with pancreatic neuroendocrine neoplasms in the US: an updated population-based study.

Authors:  Lili Lu; Yuru Shang; Christina Susanne Mullins; Xianbin Zhang; Michael Linnebacher
Journal:  Future Oncol       Date:  2021-01-06       Impact factor: 3.404

Review 3.  Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement.

Authors:  Romain Coriat; Thomas Walter; Benoît Terris; Anne Couvelard; Philippe Ruszniewski
Journal:  Oncologist       Date:  2016-07-08

Review 4.  The New World Health Organization Classification for Pancreatic Neuroendocrine Neoplasia.

Authors:  Frediano Inzani; Gianluigi Petrone; Guido Rindi
Journal:  Endocrinol Metab Clin North Am       Date:  2018-07-11       Impact factor: 4.741

Review 5.  Effect of hormone secretory syndromes on neuroendocrine tumor prognosis.

Authors:  Wouter T Zandee; Kimberly Kamp; Roxanne C van Adrichem; Richard A Feelders; Wouter W de Herder
Journal:  Endocr Relat Cancer       Date:  2017-05-08       Impact factor: 5.678

6.  Comparison of different anti-Ki67 antibody clones and hot-spot sizes for assessing proliferative index and grading in pancreatic neuroendocrine tumours using manual and image analysis.

Authors:  Roisin Owens; Elaine Gilmore; Victoria Bingham; Christopher Cardwell; Hilary McBride; Stephen McQuaid; Matthew Humphries; Paul Kelly
Journal:  Histopathology       Date:  2020-09-02       Impact factor: 5.087

Review 7.  Pancreatic Neuroendocrine Neoplasms: 2020 Update on Pathologic and Imaging Findings and Classification.

Authors:  Lokesh Khanna; Srinivasa R Prasad; Abhijit Sunnapwar; Sainath Kondapaneni; Anil Dasyam; Varaha S Tammisetti; Umber Salman; Alia Nazarullah; Venkata S Katabathina
Journal:  Radiographics       Date:  2020-08-14       Impact factor: 5.333

8.  Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.

Authors:  Arvind Dasari; Chan Shen; Daniel Halperin; Bo Zhao; Shouhao Zhou; Ying Xu; Tina Shih; James C Yao
Journal:  JAMA Oncol       Date:  2017-10-01       Impact factor: 31.777

Review 9.  Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas.

Authors:  Bryan Oronsky; Patrick C Ma; Daniel Morgensztern; Corey A Carter
Journal:  Neoplasia       Date:  2017-11-05       Impact factor: 5.715

10.  A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal.

Authors:  Guido Rindi; David S Klimstra; Behnoush Abedi-Ardekani; Sylvia L Asa; Frederik T Bosman; Elisabeth Brambilla; Klaus J Busam; Ronald R de Krijger; Manfred Dietel; Adel K El-Naggar; Lynnette Fernandez-Cuesta; Günter Klöppel; W Glenn McCluggage; Holger Moch; Hiroko Ohgaki; Emad A Rakha; Nicholas S Reed; Brian A Rous; Hironobu Sasano; Aldo Scarpa; Jean-Yves Scoazec; William D Travis; Giovanni Tallini; Jacqueline Trouillas; J Han van Krieken; Ian A Cree
Journal:  Mod Pathol       Date:  2018-08-23       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.